Annual Working Capital
$109.37 M
-$41.99 M-27.74%
01 December 2023
Summary:
Oramed Pharmaceuticals annual working capital is currently $109.37 million, with the most recent change of -$41.99 million (-27.74%) on 01 December 2023. During the last 3 years, it has fallen by -$31.20 million (-22.19%). ORMP annual working capital is now -27.74% below its all-time high of $151.36 million, reached on 31 December 2022.ORMP Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$137.50 M
-$12.04 M-8.05%
01 September 2024
Summary:
Oramed Pharmaceuticals quarterly working capital is currently $137.50 million, with the most recent change of -$12.04 million (-8.05%) on 01 September 2024. Over the past year, it has increased by +$28.13 million (+25.72%). ORMP quarterly working capital is now -10.51% below its all-time high of $153.65 million, reached on 30 September 2022.ORMP Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORMP Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +25.7% |
| 3 y3 years | -22.2% | -5.0% |
| 5 y5 years | +290.4% | +426.8% |
ORMP Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -27.7% | at low | -10.5% | +41.0% |
| 5 y | 5 years | -27.7% | +290.4% | -10.5% | +465.1% |
| alltime | all time | -27.7% | >+9999.0% | -10.5% | >+9999.0% |
Oramed Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $137.50 M(-8.0%) |
| June 2024 | - | $149.54 M(+4.2%) |
| Mar 2024 | - | $143.54 M(+31.2%) |
| Dec 2023 | $109.37 M(-27.7%) | $109.37 M(+12.1%) |
| Sept 2023 | - | $97.53 M(-34.9%) |
| June 2023 | - | $149.90 M(-0.2%) |
| Mar 2023 | - | $150.19 M(-0.8%) |
| Dec 2022 | $151.36 M(+7.7%) | $151.36 M(-1.5%) |
| Sept 2022 | - | $153.65 M(+19.6%) |
| June 2022 | - | $128.45 M(-6.4%) |
| Mar 2022 | - | $137.24 M(-5.1%) |
| Dec 2021 | $140.57 M(+58.6%) | - |
| Nov 2021 | - | $144.67 M(+63.2%) |
| Aug 2021 | $88.66 M(+146.4%) | $88.66 M(+33.4%) |
| May 2021 | - | $66.48 M(+29.0%) |
| Feb 2021 | - | $51.54 M(+70.2%) |
| Nov 2020 | - | $30.28 M(-15.8%) |
| Aug 2020 | $35.98 M(+28.4%) | $35.98 M(-3.2%) |
| May 2020 | - | $37.17 M(+52.7%) |
| Feb 2020 | - | $24.33 M(-6.8%) |
| Nov 2019 | - | $26.10 M(-6.8%) |
| Aug 2019 | $28.02 M(+5.8%) | $28.02 M(+31.1%) |
| May 2019 | - | $21.37 M(-12.8%) |
| Feb 2019 | - | $24.50 M(-3.9%) |
| Nov 2018 | - | $25.49 M(-3.8%) |
| Aug 2018 | $26.48 M(+75.0%) | $26.48 M(+47.6%) |
| May 2018 | - | $17.95 M(+9.4%) |
| Feb 2018 | - | $16.41 M(+17.1%) |
| Nov 2017 | - | $14.01 M(-7.4%) |
| Aug 2017 | $15.13 M(-45.2%) | $15.13 M(-29.0%) |
| May 2017 | - | $21.31 M(-14.2%) |
| Feb 2017 | - | $24.85 M(-3.5%) |
| Nov 2016 | - | $25.76 M(-6.7%) |
| Aug 2016 | $27.61 M(+73.8%) | $27.61 M(+16.0%) |
| May 2016 | - | $23.80 M(-2.9%) |
| Feb 2016 | - | $24.52 M(+76.6%) |
| Nov 2015 | - | $13.88 M(-12.6%) |
| Aug 2015 | $15.88 M | $15.88 M(-4.0%) |
| May 2015 | - | $16.54 M(-6.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2015 | - | $17.69 M(-25.4%) |
| Nov 2014 | - | $23.71 M(+13.9%) |
| Aug 2014 | $20.80 M(+155.4%) | $20.80 M(+34.4%) |
| May 2014 | - | $15.47 M(-33.7%) |
| Feb 2014 | - | $23.34 M(+218.9%) |
| Nov 2013 | - | $7.32 M(-10.2%) |
| Aug 2013 | $8.15 M(+75.9%) | $8.15 M(+86.1%) |
| May 2013 | - | $4.38 M(-20.0%) |
| Feb 2013 | - | $5.47 M(-15.5%) |
| Nov 2012 | - | $6.47 M(+39.7%) |
| Aug 2012 | $4.63 M(+20.5%) | $4.63 M(+120.3%) |
| May 2012 | - | $2.10 M(-16.8%) |
| Feb 2012 | - | $2.53 M(-26.6%) |
| Nov 2011 | - | $3.44 M(-10.5%) |
| Aug 2011 | $3.84 M(+309.6%) | $3.84 M(-15.9%) |
| May 2011 | - | $4.57 M(+39.8%) |
| Feb 2011 | - | $3.27 M(+252.4%) |
| Nov 2010 | - | $927.60 K(-1.1%) |
| Aug 2010 | $938.20 K(-66.6%) | $938.20 K(-46.9%) |
| May 2010 | - | $1.77 M(-18.7%) |
| Feb 2010 | - | $2.17 M(-12.0%) |
| Nov 2009 | - | $2.47 M(-12.0%) |
| Aug 2009 | $2.81 M(-37.4%) | $2.81 M(+1.0%) |
| May 2009 | - | $2.78 M(-9.5%) |
| Feb 2009 | - | $3.07 M(-13.7%) |
| Nov 2008 | - | $3.56 M(-20.7%) |
| Aug 2008 | $4.48 M(+786.1%) | $4.48 M(+1152.5%) |
| May 2008 | - | $358.00 K(+23.4%) |
| Feb 2008 | - | $290.00 K(-55.9%) |
| Nov 2007 | - | $657.00 K(+29.8%) |
| Aug 2007 | $506.00 K(-216.9%) | $506.00 K(-165.2%) |
| May 2007 | - | -$775.70 K(+33.2%) |
| Feb 2007 | - | -$582.50 K(+17.6%) |
| Nov 2006 | - | -$495.40 K(+14.5%) |
| Aug 2006 | -$432.70 K(+865.8%) | -$432.70 K(+142.7%) |
| May 2006 | - | -$178.30 K(+246.9%) |
| Feb 2006 | - | -$51.40 K(+3.2%) |
| Nov 2005 | - | -$49.80 K |
| Aug 2005 | -$44.80 K | - |
FAQ
- What is Oramed Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals quarterly working capital year-on-year change?
What is Oramed Pharmaceuticals annual working capital?
The current annual working capital of ORMP is $109.37 M
What is the all time high annual working capital for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high annual working capital is $151.36 M
What is Oramed Pharmaceuticals quarterly working capital?
The current quarterly working capital of ORMP is $137.50 M
What is the all time high quarterly working capital for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high quarterly working capital is $153.65 M
What is Oramed Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, ORMP quarterly working capital has changed by +$28.13 M (+25.72%)